| Victor O Brooks, MD | |
|
1525 W Court St, Pasco, WA 99301 | |
| (509) 542-9285 | |
| (509) 542-9285 |
| Full Name | Victor O Brooks |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1525 W Court St, Pasco, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477689834 | NPI | - | NPPES |
| 1029743 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD00024811 (Washington) | Primary |
| 207VX0000X | Obstetrics & Gynecology - Obstetrics | MD00024811 (Washington) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Victor O Brooks, MD 1525 W Court St, Pasco, WA 99301-4070 Ph: (509) 542-9285 | Victor O Brooks, MD 1525 W Court St, Pasco, WA 99301 Ph: (509) 542-9285 |
News Archive
When cancer strikes, it may be possible for patients to fight back with their own defenses, using a strategy known as immunotherapy. According to a new study published in Nature, researchers have found a way to enhance the effects of this therapeutic approach in glioblastoma, a deadly type of brain cancer, and possibly improve patient outcomes.
Life Technologies Corporation, a provider of innovative life science solutions, today announced the launch of its next-generation Qubit® 2.0 Fluorometer specifically for molecular biology researchers who work with precious samples and perform applications that require a large financial or time investment. The new system quantitates DNA, RNA and protein with accuracy, sensitivity, speed and ease-of-use.
The pathogenesis of chronic hepatitis C is associated with severe oxidative stress and non-selective immunological disturbance that lead to necroinflammation and the progression of fibrosis. Several trials have suggested that antioxidant and immunostimulant therapies may have a beneficial effect. Two previous clinical studies have reported that the Viusid related effect on histologic features, especially fibrosis, appears to be associated with antioxidant and/or immunomodulatory properties.
A final analysis of the Phase 3 COU-AA-302 trial presented today at the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid, Spain showed that ZYTIGA® (abiraterone acetate) plus prednisone significantly prolonged overall survival (OS), compared to an active control of placebo plus prednisone, in men with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC).
› Verified 3 days ago
Cheryl Hipolito, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 515 W Court St, Pasco, WA 99301 Phone: 509-547-2204 | |
Juan Carlos Hernandez Umana, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3905 Sandifur Parkway, Pasco, WA 99301 Phone: 509-942-3170 Fax: 509-543-9795 | |
Dr. Travis Alexander Najera, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1620 N Road 44, Pasco, WA 99301 Phone: 509-396-3001 Fax: 509-544-2158 | |
Dr. Kathryn L Soudah, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5025 Rd 68 Ste G #186, Pasco, WA 99301 Phone: 541-567-5305 | |
Raymond Edward Kania, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5304 N Road 68, Pasco, WA 99301 Phone: 509-543-9300 | |
Thomas Kevin Westhusing, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 N 14th Ave, Suite 400, Pasco, WA 99301 Phone: 509-545-6220 Fax: 509-547-0894 | |
Dr. Marshall Keith Brown, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5304 Road 68, Pasco, WA 99301 Phone: 509-543-9300 |